Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2016 of 6351
-
Lab-Grown tumor clones could guide cancer therapy
Knowledge-focused Recruiting nowThe emergence of tumor organoid cultures in recent years has made it possible to widen the repertoire of available preclinical tumor models and to bridge the gap between cell lines and tumors of xenografted patients in mice (PDXs).These organoids have the advantages of being able…
Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Nanoparticles + radiation: new hope against tough pancreatic cancer?
Disease control OngoingTo find the recommended dose of NBTXR3 that can be given in combination with radiation therapy to patients with pancreatic cancer. To learn if the dose NBTXR3 found in Part 1 can help to control the disease.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a vitamin and herb blend tame the Body's stress response?
Symptom relief CompletedThe aim is to study the effect of a dietary supplement on stress and pain through questionnaires and follow-up of physiological parameters, and functional Magnetic Resonance Imaging (fMRI) in stressed healthy subjects versus stressed healthy subjects without treatment.
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Zapping cancer spots could delay stronger drugs
Disease control Recruiting nowEvery year, 12500 primary renal cell carcinoma (RCC) are diagnosed in France. Metastases occur in half of RCC patients. Management of metastatic RCC is based on systemic treatments (targeted therapies/immunotherapy). However, resistance to systemic treatment is frequent. In case…
Phase 2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Scientists hunt for smarter treatments for kids with leukemia
Knowledge-focused Recruiting nowPrognosis of children with leukemia, the most common pediatric cancer, has improved markedly. Yet, relapse still occurs in 15-40% of patients with a probability of survival of \<50%, which is unlikely to be boosted by intensification of standard chemotherapy due to overwhelming t…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New drug ST101 takes on Hard-to-Treat cancers
Disease control OngoingThis is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in patients with advanced solid tumors. The study consists of two phases: a phase 1 dose escalation/regimen…
Phase 1/2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a targeted drug shrink tumors when immunotherapy fails?
Disease control Recruiting nowThis is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology c…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can we treat sicker lung cancer patients the same as healthier ones?
Disease control Recruiting nowThis pilot study is configured as a non-inferiority comparison of Performance Status 2 patients with Performance Status 0-1 patients, with the goal of demonstrating non-inferiority in terms of efficacy (progression-free survival, overall survival) and safety (rates of adverse eve…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Old heart drug gets a second look: can low doses save lives?
Disease control CompletedDigoxin is the oldest, market-authorized drug for heart failure (HF), and very cheap. A large trial with digoxin, the DIG trial, executed in the early nineties revealed a highly significant reduction in HF hospitalizations, but no effect on mortality. A post-hoc analysis of the D…
Phase 4 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Blood test could reveal how lung cancer evolves during treatment
Knowledge-focused CompletedTo evaluate the predictive value of ctDNA in response, relapse for patients treated with immune checkpoint inhibitors or targeted therapy for ALK, ROS1, MET ex14 skipping.
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can a smartwatch replace the clinic walk test for lung disease patients?
Knowledge-focused Completed* Evaluate for accuracy and reproducibility of data collected via the participant-operated Walk.Talk.Track. (WTT) app combined with Apple Watch during in-clinic, technician proctored 6MWT's. * Determine whether the WTT app on the Apple Watch can accurately collect information …
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New drug aims to reignite immune attack on Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine fusion protein IL12-L19L19 in patients with advanced or metastatic solid carcinomas, after previous immune checkpoint blockade therapy. The primary objective of…
Phase 1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Acupuncture may slash opioid use in cancer patients
Symptom relief OngoingThe purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Smarter prostate cancer detection: new combo test aims to reduce unnecessary biopsies
Diagnosis OngoingThe purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood and urine biomarkers is more effective at detecting prostate cancer than standard of care…
Sponsor: University of Miami • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Which thumb arthritis surgery works best? a Head-to-Head trial aims to find out
Disease control Recruiting nowThe purpose of this study is to evaluate the basis for three widely held fundamental tenets about surgical intervention for thumb basal joint arthritis; 1. Trapeziectomy with ligament reconstruction and metacarpal stabilization is associated with superior functional outcomes and…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyPrimary Objectives: Primary population (adult participants with late-onset GM2 gangliosidosis): To assess the efficacy and pharmacodynamics (PD) of daily oral dosing of venglustat when administered over a 104-week period Secondary population (participants with juvenile/adolesce…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to reboot immunotherapy in resistant cancers
Disease control Recruiting nowPhase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
Phase 1/2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a vitamin e boost chemo for advanced colon cancer?
Disease control OngoingThis double blind, randomized phase II trial will investigate whether the addition of tocotrienol will improve the effect and lower the toxicity of standard chemotherapy and bevacizumab. Half of the patients will receive tocotrienol and the other half placebo. Treatment is planne…
Phase 2 • Sponsor: Vejle Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Walking program shows promise for easing fatigue in metastatic breast cancer
Symptom relief CompletedINTRODUCTION: Patients with a metastatic breast cancer suffer from a deteriorated quality of life and numerous symptoms such as pain, severe fatigue and a decrease of their physical fitness. As the feasibility of a physical activity program has been demonstrated in this populatio…
Sponsor: Centre Leon Berard • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Estrogen plus talk therapy shows promise for PTSD in women
Symptom relief CompletedThe purpose of this research study is to determine if taking a pill of estradiol (E2) together with prolonged exposure (PE) therapy can improve this treatment outcome in women diagnosed with Post-Traumatic Stress Disorder (PTSD). 80 subjects will take part in this research study …
Phase 3 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC